±¹³»µµ¼
Àü°øµµ¼/´ëÇб³Àç
ÀǾàÇа£È£°è¿
2013³â 9¿ù 9ÀÏ ÀÌÈÄ ´©Àû¼öÄ¡ÀÔ´Ï´Ù.
Á¤°¡ |
140,000¿ø |
---|
126,000¿ø (10%ÇÒÀÎ)
1,400P (1%Àû¸³)
ÇÒÀÎÇýÅÃ | |
---|---|
Àû¸³ÇýÅà |
|
|
|
Ãß°¡ÇýÅÃ |
|
À̺¥Æ®/±âȹÀü
¿¬°üµµ¼
»óÇ°±Ç
ÀÌ»óÇ°ÀÇ ºÐ·ù
Ã¥¼Ò°³
ÀÌ Ã¥Àº ±¹³» Ç÷°üÁúȯ °ü·Ã ±³¼ö ¹× Àü¹®ÀÇ 43¸íÀÌ °øµ¿ ÁýÇÊ(ÆíÀú, ±è¿µ¿í)ÇÑ ÀÇÇмÀûÀ¸·Î º¹ºÎ´ëµ¿¸Æ·ù(abdominal aortic aneurysm) ¶ó´Â ¿ì¸®³ª¶ó¿¡¼´Â ºñ±³Àû ÈçÄ¡ ¾ÊÀº ÁúȯÀ» ÁÖÁ¦·Î 56°³ÀÇ ºÐ¾ß·Î ¼¼ºÐÇÏ¿© ÀÌ ÁúȯÀÇ ¹ß»ý±âÀü, ¿¹ÈÄ, Ä¡·á¹æ¹ý ¹× Ä¡·á¿Í °ü·ÃµÈ ÇÕº´Áõ±îÁö »ó¼¼ÇÏ°Ô ±â¼úÇÑ Àü¹® ¼ÀûÀÌ´Ù. ƯÈ÷ ÃÖ±Ù ¸¹ÀÌ ½ÃÇàµÇ°í ÀÖ´Â º¹ºÎ´ëµ¿¸Æ·ù Ç÷°ü ³» ½Ã¼ú(endovascular aortic aneurysm repair, EVAR)°ú ¼ö¼úÀû Ä¡·á ¹æ¹ý¿¡ °üÇØ ÁýÁßÀûÀ¸·Î ±â¼úµÇ¾î ÀÖ´Ù.
ºÎ·Ï±îÁö ÇÕÃļ ÃÑ 604 ÆäÀÌÁö¿¡ ´ÞÇÏ´Â ÇѱÛÆÇ Ã¥À¸·Î ¼ö¼úÀ̳ª ½Ã¼ú ¹æ¹ýÀº Àü¹® illustratorÀÇ µµ¿òÀ» ¹Þ¾Æ °¡´ÉÇÑ ÇÑ ½ÇÁ¦¸ð¾ç°ú À¯»çÇÏ°Ô ¹¦»çµÇ¾úÀ¸¸ç, ÇѱÛÆÇÀÌÁö¸¸ ¾î´À ¿Ü±¹ ¼Àû ¸øÁö¾ÊÀº Ãæ½ÇÇÑ ³»¿ëÀ» ´ã°í ÀÖ´Ù°í ÀúÀÚ µéÀº ¸»ÇÏ°í ÀÖ´Ù.
ÁýÇÊÁøÀº Ç÷°ü¿Ü°ú, ¼øȯ±â ³»°ú, ÈäºÎ¿Ü°ú, ¿µ»óÀÇÇаú, ÁßȯÀÚ ÀÇÇаú, ·ù¸¶Æ¼½º ³»°ú, °¨¿° ³»°ú, ¸¶Ãë°ú µî ´Ù¾çÇÑ ºÐ¾ßÀÇ Àü¹®°¡µé·Î ±¸¼ºµÇ¾î ÀÖÀ¸¸ç, ´ëÇ¥ ÀúÀÚ´Â (Çö) °ºÏ»ï¼ºº´¿ø Ç÷°ü¿Ü°ú, (Àü) »ï¼º¼¿ïº´¿ø Ç÷°ü¿Ü°ú, ¼º±Õ°üÀÇ´ë ±³¼ö, (Àü) ´ëÇÑ Ç÷°ü¿Ü°úÇÐȸ ȸÀåÀÎ ±è¿µ¿í ±³¼öÀÌ´Ù.
ÀÌ Ã¥Àº ÀϹÝÀε鿡°Ô´Â º¹ºÎ´ëµ¿¸Æ·ù¶ó´Â Áúȯ¿¡ ´ëÇÑ ÀÇÇÐ Á¤º¸¸¦ Á¦°øÇÒ ¼ö ÀÖ°í, Çлý, ÀÇ»ç ¹× ÀÇ·á °ü·ÃÀڵ鿡°Ô´Â º¹ºÎ´ëµ¿¸Æ·ù ȯÀÚÀÇ Ä¡·á Áöħ¼·Î¼ È°¿ëµÉ ¼ö ÀÖ´Ù°í »ý°¢ÇÑ´Ù.
ÃâÆÇ»ç ¼Æò
ÀÌ Ã¥À» ¹ß°£ÇÏ¸é¼ ÈǸ¢ÇÑ ¿ø°í¸¦ ¾²¼ º¸³»ÁֽŠ¿©·¯ ÀúÀںе鲲 ¸ÕÀú ±íÀº °¨»ç¸¦ µå¸³´Ï´Ù.
ÇÊÀÚ°¡ ÀÇ°ú´ëÇÐÀ» ´Ù´Ï´ø ½ÃÀý¿¡´Â º¹ºÎ´ëµ¿¸Æ·ù(abdominal aortic aneurysm, AAA)¶ó´Â º´Àº ¼¾çÀε鿡¼ »ý±â´Â ÁúȯÀ¸·Î ¿©°Ü¿Ô¾ú°í, ÀÌ º´¿¡ ´ëÇØ °ÀǸ¦ µéÀº ±â¾ïÀÌ º°·Î ¾ø¾ú½À´Ï´Ù. ±ÙÀÚ¿¡ ¿ì¸® »çȸ¿¡¼µµ º¹ºÎ´ëµ¿¸Æ·ù°¡ ÈçÈ÷ ¹ß°ßµÇ´Â °ÍÀº ¹ßº´·üÀÌ Áõ°¡ÇÑ Å¿µµ ÀÖ°ÚÁö¸¸, ¿ì¸® »çȸ¿¡ CT³ª ÃÊÀ½ÆÄ°Ë»ç °°Àº ¿µ»óÀÇÇÐ Áø´ÜÀÌ º¸ÆíÈµÇ¸é¼ ±×°£ Áø´ÜµÇÁö ¾Ê¾Ò´ø ȯÀÚµéÀÌ ºñ±³Àû ªÀº ±â°£ µ¿¾È¿¡ ¸¹ÀÌ »öÃâµÈ È¿°úµµ ÀÖ´Ù°í »ý°¢ÇÕ´Ï´Ù.
º¹ºÎ´ëµ¿¸Æ·ù´Â ±¸¹Ì¿¡¼´Â °¡Àå ÈçÇÑ µ¿¸ÆÁúȯÀÎ ÇÏÁöµ¿¸Æ Æó»öÁõ, °æµ¿¸Æ ÇùÂøÁõ°ú ÇÔ²² Ç÷°üÀÇÇÐ ¿µ¿ªÀÇ Áß¿äÇÑ ÁúȯÀÇ Çϳª·Î ÀÌ¹Ì Àß ¾Ë·ÁÁ® ÀÖ´ø ÁúȯÀÔ´Ï´Ù.
ÇÊÀÚ´Â Ç÷°ü¿Ü°ú ÀÇ»ç·Î¼ Áö±Ý±îÁö °æÇèÇÑ ¼ö¼ú ȯÀÚµé Áß Âü´ãÇÑ ½Ã·ÃÀ» ¾È°ÜÁØ È¯ÀÚµµ º¹ºÎ´ëµ¿¸Æ·ù ȯÀÚ¿´°í, ¿Ü°úÀÇ»ç·Î¼ Å« º¸¶÷À» ´À³¥ ¼ö ÀÖ°Ô ÇØÁØ È¯ÀÚµµ º¹ºÎ´ëµ¿¸Æ·ù ȯÀÚ¿´´Ù°í ±â¾ïµË´Ï´Ù.
±Ù·¡¿¡ Ç÷°ü³» Ä¡·á(endovascular treatment)ÀÇ ¹ßÀü¿¡ ÈûÀÔ¾î º¹ºÎ´ëµ¿¸Æ·ùÀÇ Ä¡·á´Â ±×¾ß¸»·Î ȹ±âÀûÀ¸·Î Å« º¯È°¡ ÀÖ¾ú½À´Ï´Ù. ¹ßÀüÇÏ´Â ÀÇ·á Àåºñ¿Í ÀÇ·á±â¼ú¿¡ ÈûÀÔ¾î º¹ºÎ´ëµ¿¸Æ·ù Ä¡·á´Â ´Ù¸¥ ¾î¶°ÇÑ ºÐ¾ßÀÇ ÀÇÇк¸´Ùµµ ´õ Å« º¯È¸¦ ¸Â¾Æ¾ß¸¸ Çß½À´Ï´Ù. º¯ÈµÈ ÀÇÇп¡ ¹ß ¸ÂÃß±â À§Çؼ Áö±Ý±îÁö ½ÀµæÇÑ Áö½ÄÀ̳ª ±â¼ú°ú´Â ÀüÇô ´Ù¸¥ »õ·Î¿î ÀÇÇÐ Áö½Ä°ú ±â¼ú ½ÀµæÀ» ÇÊ¿ä·Î Çß´ø ºÐ¾ßµµ ÀÌ ºÐ¾ß¿´½À´Ï´Ù.
¸¹Àº º¯È¸¦ º¸ÀÎ ÀÇÇÐÀÇ ÇÑ ºÎºÐÀÎ º¹ºÎ´ëµ¿¸Æ·ù¸¦ ÁÖÁ¦·Î ±¹³»ÀÇ ¸¹Àº Àü¹®°¡µéÀÇ ÃֽŠÁö°ßÀ» ¸ð¾Æ¼ Ã¥À» ¹ß°£ÇÏ´Â ¸ñÀûÀº ¿ì¸®ÀÇ ÈÄÁøµéÀÌ ¿ì¸® º¸´Ù´Â Á»´õ ½±°Ô ÀÌ ºÐ¾ß¿¡ Á¢±ÙÇÒ ¼ö ÀÖµµ·Ï ÇØÁֱ⸦ Èñ¸ÁÇϱ⠶§¹®ÀÔ´Ï´Ù. ¾Æ¿ï·¯ ¹ßÀüÇÏ´Â ¿ì¸®³ª¶óÀÇ Ç÷°üÀÇÇÐ ºÐ¾ß¿¡ ÀÌ Ã¥ÀÌ ÀÛÀº µðµõµ¹ÀÌ µÇ±â¸¦ Èñ¸ÁÇÏ°í ÀÖ½À´Ï´Ù.
ƯÈ÷ Ã¥À» ÁغñÇÏ¸é¼ Àú¸¦ °¨µ¿½ÃŲ Á¡Àº º»¼ÀÇ ÁýÇÊÀ» ¸Ã¾ÆÁֽŠÀúÀÚ ºÐµéÀº °¢ÀÚ Àü¹®ºÐ¾ß°¡ ´Ù¸¥ ºÐµéÀÌ ¸¹´Ù´Â »ç½ÇÀÔ´Ï´Ù. ÀÇÇÐÀ» º¸´Â ½Ã°¢ÀÌ ´Ù¼Ò ´Ù¸¦ ¼öµµ ÀÖ´Â ¿©·¯ ºÐ¾ßÀÇ Àü¹®°¡µéÀÌ ÇÑ °¡Áö ÁúȯÀ» ÁÖÁ¦·Î ÀÚ½ÅÀÇ °ßÇظ¦ ±â¼úÇÏ°í, À̰͵éÀÌ ¸ðÀ̸é Áö½ÄÀº ´õ °ß°íÇØÁö°í, ÇÑ ºÐ¾ßÀÇ ¹ßÀüÀ» °¡Á®¿Ã ¼ö ÀÖ´Ù´Â °ÍÀ» »ý°¢ÇÒ ¶§ ÀÌ Ã¥ÀÇ ¹ß°£Àº ÀÇ¹Ì ÀÖ´Â ÀÏÀ̶ó »ý°¢ÇÕ´Ï´Ù.
¼ö¼ú¿¡ ´ëÇÑ Áö½ÄÀÌ ºÎÁ·ÇÑ »ç¶÷Àº ÀÌ Ã¥À» ÅëÇØ Ç÷°ü ¼ö¼ú¿¡ ´ëÇÑ Áö½ÄÀ» ¾òÀ» ¼ö ÀÖ°í, Ç÷°ü³» Ä¡·á¿¡ ´ëÇÑ Áö½ÄÀÌ ºÎÁ·ÇÑ »ç¶÷Àº ÀÌ Ã¥À» ÅëÇØ Ç÷°ü³» Ä¡·á¿¡ ´ëÇÑ ´õ ¸¹Àº Á¤º¸¿Í ±â¼úÀ» ½ÀµæÇϴµ¥ µµ¿òÀ» ÁÙ ¼ö ÀÖ´Ù°í »ý°¢ÇÕ´Ï´Ù.
ÀÇÇÐÀÌ ¹ßÀüÇÔ¿¡ µû¶ó °ú°Å¿¡ ¾ø¾ú´ø »õ·Î¿î Ä¡·á¹æ¹ýÀÌ ¼Ò°³µÇ°í ÀÌ¿Í °ü·ÃÇÑ »õ·Î¿î ÇÕº´ÁõµéÀÌ ³ªÅ¸³ª¹Ç·Î ÀÌ°ÍÀº ¿ì¸®°¡ ±Øº¹ÇØ¾ß ÇÒ »õ·Î¿î °úÁ¦°¡ µÇ¾ú½À´Ï´Ù.
ÇÑ ¼±¹è ±³¼ö°¡ ³»°Ô ¸»Çϱ⸦ ¡°±³¼ö°¡ µÇ¾î¼ ÀڱⰡ °¡Áö°í ÀÖ´Â Áö½ÄÀ̳ª ±â¼úÀ» ÈÄÁø¿¡°Ô ºüÁü¾øÀÌ °¡¸£ÃÄ ÁÖÁö ¾Ê´Â´Ù¸é °¡¸£Ä¡´Â »ç¶÷À¸·Î¼ ÀÚ°ÝÀÌ ¾ø´Ù.¡±¶ó°í ÇÑ ¸»À» ±â¾ïÇÕ´Ï´Ù.
¿ì¸® ¸ðµÎ°¡ ¸ÅÀÏ º¯ÈÇÏ´Â »õ·Î¿î ÀÇÇÐÀ» ¹è¿ö°£´Ù´Â °â¼ÕÇÑ ÀÚ¼¼·Î, ±×¸®°í ³ªÀÇ Áö½ÄÀ» ÁÖº¯ ´Ù¸¥ ºÐµé°ú ³ª´©¾î °¡Áø´Ù´Â ¸¶À½À¸·Î ÀÌ Ã¥ÀÇ ¹ß°£»ç¸¦ ´ë½ÅÇÏ°í ½Í½À´Ï´Ù.
ÁÁÀº Ã¥À» ¸¸µé¾î ÁÖ±â À§ÇØ ¾Ö½á ÁֽŠ¸ðµç ÀúÀÚ ±×¸®°í °¡º»ÀÇÇмÀû ÃâÆÇ ÀÓÁ÷¿øºÐµé°Ô ´Ù½Ã ÇÑ ¹ø °¨»çÀÇ ¸¶À½À» Ç¥Çϸç, ¸¶Áö¸·À¸·Î ÀÌ Ã¥ÀÌ Çлý, ÀÇÇÐÀÚ, ÀÇ·á°ü·Ã Á¾»çÀڵ鿡°Ôµµ ÁÁÀº Áöħ¼°¡ µÉ ¼ö Àֱ⸦ Èñ¸ÁÇÏ°í, ´õ ³ª¾Æ°¡ º¹ºÎ´ëµ¿¸Æ·ù ȯÀÚÀÇ Ä¡·á¿¡ Á¶±ÝÀ̳ª¸¶ µµ¿òÀÌ µÇ±â¸¦ Èñ¸ÁÇÕ´Ï´Ù.
¸ñÂ÷
SECTION 1 GENERAL
Ch 01. Pathogenesis of degenerative aortic aneurysm: hypothesis and proven evidence
Ch 02. Attempts to inhibit AAA growth: Experimental and clinical work
Ch 03. AAA in patients with connective tissue disease: characteristics, diagnosis and management
Ch 04. CAD in patients with AAA: preoperative cardiac risk evaluation
Ch 05. Ma nagement of small AAA: Surveillance versus Treatment
Ch 06. Malignant tumors accompanied with abdominal aortic aneurysm
Ch 07. Diagnosis and medical treatment of systemic vasculitis involving aorta
Ch 08. Anesthetic Management of AAA surgery
Ch 09. Inflammatory AAA and IgG4-related sclerosing disease
Ch 10. Spontaneous isolated abdominal aortic dissection
Ch 11. In fected AAA: etiology, clinical features, diagnosis and treatment
Ch 12. Basic concept of 3D printing
SECTION 2 ENDOVASCULAR TREATMENT
Ch 13. Basic endovascular skill for EVAR
Ch 14. Hybrid operation room
Ch 15. Systematized, preoperative evaluation of aorto-iliac anatomy before EVAR
Ch 16. Selection of EVAR device
Ch 17. Technical tips to reduce the amount of contrast agent during EVAR
Ch 18. Technical tips for selection of abdominal aortic branches, iliac artery and contralateral limb during EVAR
Ch 19. EVAR for patients with unfavorable aortic neck: Technical tips
Ch 20. Endovascular treatment of type IV thoraco-abdominal aortic aneurysm
Ch 21. Endovascular aneurysm repair for ruptured AAA: Technical tips and current results
Ch 22. Endoleak after EVAR: type, frequency, management and risk factors for the development of endoleak
Ch 23. Ul trasound examination for the diagnosis of endoleak after EVAR
Ch 24. Surveillance of endoleak after EVAR
Ch 25. Ne w generation EVAR device: merits and results
Ch 26. Iliac branch device (IBD)
Ch 27. Percutaneous-EVAR (PEVAR): Technical tips and clinical results
Ch 28. Chimney EVAR and terrace EVAR
Ch 29. Treatment of AAA for patients with functioning transplanted kidney
Ch 30. Brachial or axillary artery access during EVAR: Indications, technical tips and complications
Ch 31. Type Ia Endoleak: Prevention and management
Ch 32. Treatment of persistent type II endoleak after EVAR
Ch 33. Progression of sac enlargement after EVAR without endoleak: cause and management
Ch 34. How can we avoid iliac limb occlusion after EVAR?
Ch 35. Management of Iliac limb occlusion after EVAR
SECTION 3 OPEN SURGICAL TREATMENT
Ch 36. Op en surgical repair of infrarenal AAA
Ch 37. Tre atment of juxtarenal AAA: Open surgical repair versus endovascular treatment
Ch 38. Surgical approaches for suprarenal AAA Repair
Ch 39. Op en surgical repair of type IV thoracoabdominal aortic aneurysm
Ch 40. Cardiopulmonary bypass used in open surgical repair of the TAAA
Ch 41. Treatment of infected aortic aneurysm or aortic prosthesis infection
Ch 42. Treatment of inflammatory AAA
Ch 43. Op en surgical repair of ruptured AAA
Ch 44. Open conversion after EVAR
Ch 45. Aortoenteric fistula
Ch 46. Hybrid procedure for patients with thoraco-abdominal aneurysm
Ch 47. EVAR with surgical reconstruction of hypogastric artery: Indication, surgical technique
SECTION 4 POSTOPERATIVE COMPLICATIONS AND MANAGEMENT
Ch 48. Critical care for patients with massive hemorrhag
Ch 49. Management of AAA patients in the ICU
Ch 50. Abdominal compartment syndrome after open repair of the rAAA: definition and management
Ch 51. Sexual dysfunction after open surgical repair of AAA: Causes and preventions
Ch 52. Chylous ascites after open surgical repair of AAA
Ch 53. Renal protection during the aortic surgery requiring suprarenal aortic cross clamping
Ch 54. Differential diagnosis and management of perioperative acute kidney injury in AAA patients
Ch 55. Postoperative colonic ischemia after AAA repair
Ch 56. Post-implantation syndrome (PIS) following EVAR
ºÎ·Ï
°¢Á¾ EVAR deviceÀÇ Æ¯Â¡°ú »ç¿ë¹æ¹ý ¹× Ä¡·á¼ºÀû
ºÎ·Ï 1 EndurantTM IIs (Medtronic Co.)
ºÎ·Ï 2 AFX2¢ç (Endologix Inc.)
ºÎ·Ï 3 INCRAFT¢ç stent graft (Cardinal Health Inc.)
ºÎ·Ï 4 Zenith¢ç Flex (Cook Medical Co.)
ã¾Æº¸±â
ÀúÀÚ¼Ò°³
»ý³â¿ùÀÏ | - |
---|
ÇØ´çÀÛ°¡¿¡ ´ëÇÑ ¼Ò°³°¡ ¾ø½À´Ï´Ù.
ÁÖ°£·©Å·
´õº¸±â»óÇ°Á¤º¸Á¦°ø°í½Ã
À̺¥Æ® ±âȹÀü
Àü°øµµ¼/´ëÇб³Àç ºÐ¾ß¿¡¼ ¸¹Àº ȸ¿øÀÌ ±¸¸ÅÇÑ Ã¥
ÆǸÅÀÚÁ¤º¸
»óÈ£ |
(ÁÖ)±³º¸¹®°í |
---|---|
´ëÇ¥ÀÚ¸í |
¾Èº´Çö |
»ç¾÷ÀÚµî·Ï¹øÈ£ |
102-81-11670 |
¿¬¶ôó |
1544-1900 |
ÀüÀÚ¿ìÆíÁÖ¼Ò |
callcenter@kyobobook.co.kr |
Åë½ÅÆǸž÷½Å°í¹øÈ£ |
01-0653 |
¿µ¾÷¼ÒÀçÁö |
¼¿ïƯº°½Ã Á¾·Î±¸ Á¾·Î 1(Á¾·Î1°¡,±³º¸ºôµù) |
±³È¯/ȯºÒ
¹ÝÇ°/±³È¯ ¹æ¹ý |
¡®¸¶ÀÌÆäÀÌÁö > Ãë¼Ò/¹ÝÇ°/±³È¯/ȯºÒ¡¯ ¿¡¼ ½Åû ¶Ç´Â 1:1 ¹®ÀÇ °Ô½ÃÆÇ ¹× °í°´¼¾ÅÍ(1577-2555)¿¡¼ ½Åû °¡´É |
---|---|
¹ÝÇ°/±³È¯°¡´É ±â°£ |
º¯½É ¹ÝÇ°ÀÇ °æ¿ì Ãâ°í¿Ï·á ÈÄ 6ÀÏ(¿µ¾÷ÀÏ ±âÁØ) À̳»±îÁö¸¸ °¡´É |
¹ÝÇ°/±³È¯ ºñ¿ë |
º¯½É ȤÀº ±¸¸ÅÂø¿À·Î ÀÎÇÑ ¹ÝÇ°/±³È¯Àº ¹Ý¼Û·á °í°´ ºÎ´ã |
¹ÝÇ°/±³È¯ ºÒ°¡ »çÀ¯ |
·¼ÒºñÀÚÀÇ Ã¥ÀÓ ÀÖ´Â »çÀ¯·Î »óÇ° µîÀÌ ¼Õ½Ç ¶Ç´Â ÈÑ¼ÕµÈ °æ¿ì ·¼ÒºñÀÚÀÇ »ç¿ë, Æ÷Àå °³ºÀ¿¡ ÀÇÇØ »óÇ° µîÀÇ °¡Ä¡°¡ ÇöÀúÈ÷ °¨¼ÒÇÑ °æ¿ì ·º¹Á¦°¡ °¡´ÉÇÑ »óÇ° µîÀÇ Æ÷ÀåÀ» ÈѼÕÇÑ °æ¿ì ·½Ã°£ÀÇ °æ°ú¿¡ ÀÇÇØ ÀçÆǸŰ¡ °ï¶õÇÑ Á¤µµ·Î °¡Ä¡°¡ ÇöÀúÈ÷ °¨¼ÒÇÑ °æ¿ì ·ÀüÀÚ»ó°Å·¡ µî¿¡¼ÀÇ ¼ÒºñÀÚº¸È£¿¡ °üÇÑ ¹ý·üÀÌ Á¤ÇÏ´Â ¼ÒºñÀÚ Ã»¾àöȸ Á¦ÇÑ ³»¿ë¿¡ ÇØ´çµÇ´Â °æ¿ì |
»óÇ° Ç°Àý |
°ø±Þ»ç(ÃâÆÇ»ç) Àç°í »çÁ¤¿¡ ÀÇÇØ Ç°Àý/Áö¿¬µÉ ¼ö ÀÖÀ½ |
¼ÒºñÀÚ ÇÇÇغ¸»ó |
·»óÇ°ÀÇ ºÒ·®¿¡ ÀÇÇÑ ±³È¯, A/S, ȯºÒ, Ç°Áúº¸Áõ ¹× ÇÇÇغ¸»ó µî¿¡ °üÇÑ »çÇ×Àº¼ÒºñÀÚºÐÀïÇØ°á ±âÁØ (°øÁ¤°Å·¡À§¿øȸ °í½Ã)¿¡ ÁØÇÏ¿© ó¸®µÊ ·´ë±Ý ȯºÒ ¹× ȯºÒÁö¿¬¿¡ µû¸¥ ¹è»ó±Ý Áö±Þ Á¶°Ç, ÀýÂ÷ µîÀº ÀüÀÚ»ó°Å·¡ µî¿¡¼ÀǼҺñÀÚ º¸È£¿¡ °üÇÑ ¹ý·ü¿¡ µû¶ó ó¸®ÇÔ |
(ÁÖ)ÀÎÅÍÆÄÅ©Ä¿¸Ó½º´Â ȸ¿ø´ÔµéÀÇ ¾ÈÀü°Å·¡¸¦ À§ÇØ ±¸¸Å±Ý¾×, °áÁ¦¼ö´Ü¿¡ »ó°ü¾øÀÌ (ÁÖ)ÀÎÅÍÆÄÅ©Ä¿¸Ó½º¸¦ ÅëÇÑ ¸ðµç °Å·¡¿¡ ´ëÇÏ¿©
(ÁÖ)KGÀ̴Ͻýº°¡ Á¦°øÇÏ´Â ±¸¸Å¾ÈÀü¼ºñ½º¸¦ Àû¿ëÇÏ°í ÀÖ½À´Ï´Ù.
¹è¼Û¾È³»
±³º¸¹®°í »óÇ°Àº Åùè·Î ¹è¼ÛµÇ¸ç, Ãâ°í¿Ï·á 1~2Àϳ» »óÇ°À» ¹Þ¾Æ º¸½Ç ¼ö ÀÖ½À´Ï´Ù.
Ãâ°í°¡´É ½Ã°£ÀÌ ¼·Î ´Ù¸¥ »óÇ°À» ÇÔ²² ÁÖ¹®ÇÒ °æ¿ì Ãâ°í°¡´É ½Ã°£ÀÌ °¡Àå ±ä »óÇ°À» ±âÁØÀ¸·Î ¹è¼ÛµË´Ï´Ù.
±ººÎ´ë, ±³µµ¼Ò µî ƯÁ¤±â°üÀº ¿ìü±¹ Åù踸 ¹è¼Û°¡´ÉÇÕ´Ï´Ù.
¹è¼Ûºñ´Â ¾÷ü ¹è¼Ûºñ Á¤Ã¥¿¡ µû¸¨´Ï´Ù.